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Abstract The trefoil factor family protein, TFF1, forms a
homodimer, via a disulphide linkage, that has greater activity in
wound healing assays than the monomer. Having previously
determined a high-resolution solution structure of a monomeric
analogue of TFF1, we now investigate the structure of the
homodimer formed by the native sequence. The two putative
receptor/ligand recognition domains are found to be well
separated, at opposite ends of a flexible linker. This contrasts
sharply with the known fixed and compact arrangement of the
two trefoil domains of the closely related TFF2, and has
significant implications for the mechanism of action and
functional specificity of the TFF of proteins. ß 2001 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
The trefoil factor family (TFF) proteins are secreted pro-
teins produced in large quantities in epithelial mucosa and
appear to have an important role in maintenance of mucosal
integrity of the gastrointestinal tract. Members of the family
comprise one or more trefoil domains [1]. The trefoil motif
consists of V40 amino acids with several well-conserved fea-
tures including six cysteine residues with essentially conserved
spacings. Three closely related human TFF proteins are
known. Human TFF1, previously known as pS2 or pNR-2,
is a small, secreted protein of 60 amino acid residues and
contains a single trefoil domain [2^5]. TFF3, previously des-
ignated intestinal trefoil factor, consists of 59 residues and
also contains a single trefoil domain [6,7]. TFF2, previously
called spasmolytic polypeptide, contains two trefoil domains
in a single chain of 106 amino acids [8].
The physiological e¡ects of the human trefoil proteins have
been extensively investigated and reviewed [9,10] in recent
years. These proteins are found in many cancers, including
those of the breast and pancreas. This discovery, together
with the ¢nding that gastric tumours increase in mice lacking
TFF1 [11], has stimulated much research in cancer-related
areas [12]. However, presently much more is known about
the role of trefoil proteins in normal tissue, where it seems
highly likely that they have an important active role in wound
healing in the mucosal epithelia of the gut. All three human
trefoil proteins promote cell motility in cultured cells [13^15].
In TFF1, homodimerisation can take place via the formation
of an intermolecular disulphide bond between the Cys58 resi-
dues of the two monomers [16]. Dimers of TFF1 and TFF3
have been identi¢ed in several tissues [16^18]. Furthermore, it
has been shown that dimerisation of TFF1 plays a key role in
both its motogenic and protective/healing e¡ects [15]. It is
plausible therefore that the biologically potent forms of all
three of the human trefoil proteins contain two trefoil do-
mains. The molecular mechanisms of the trefoil proteins pro-
tective and motogenic e¡ects are not understood and may
involve several distinct processes. The three trefoil proteins
show distinct patterns of expression in normal and diseased
tissue suggesting that each has distinct functions and possibly
separate receptors. The proteins may be involved in the pro-
cessing of mucin glycoproteins or formation of mucous struc-
tures [6,18]. It has been suggested that as the active forms of
the molecule are dimeric the trefoil proteins may cross-link the
mucin glycoproteins thereby stabilising the mucous layer [19].
Their role in promoting movement in wounded cells may in-
volve recognition by speci¢c receptors and the e¡ects of TFF1
dimerisation suggest that the receptors may be involved in a
bivalent interaction with surface residues from two trefoil do-
mains.
Three-dimensional (3D) structures have been determined
for three trefoil domains, one from human TFF1 [20] and
two from porcine TFF2 [19,21,22]. The structures show that
the cysteines pair in a 1^5, 2^4, 3^6 manner, forming a struc-
ture comprising three closely packed loops, with the third
loop sandwiched between the ¢rst and second. A short K-helix
is packed against two anti-parallel L-strands (Fig. 1). The
conserved surface residues are localised in a small area on
adjacent parts of the second and third loops, strongly suggest-
ing that this area is a receptor/ligand binding site [19^21].
The N- and C-termini of porcine TFF2 are linked by a
seventh disulphide bond, which helps to ¢x the relative ori-
entation of its two trefoil domains. This produces a compact
structure with the two domains in direct contact and the pu-
tative binding sites of each domain separated by 44 Aî (dis-
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tance between the CK atoms of Pro22 and Pro71) and facing
away from each other. Both TFF1 and TFF3 have a seventh
cysteine residue close to the C-terminus (Cys58 in TFF1), ca-
pable of forming intermolecular disulphide bonds [16,17]. In
our earlier study of TFF1 dimerisation was deliberately pre-
vented by introducing a Ser58 mutation [23]. The resulting
monomeric protein provided excellent spectra that allowed
us to make essentially complete resonance assignments and
to determine a high-resolution 3D solution structure [20,24].
We now report the structure of the dimeric form of the native
protein.
2. Materials and methods
2.1. Protein expression and puri¢cation
The detailed protocols for the production and puri¢cation of the
recombinant proteins have been described previously [16,20,23].
Brie£y, the unlabelled proteins were puri¢ed from the periplasm of
Escherichia coli HB101 cells transfected with pEZZ18:TFF1 Cys58 or
TFF1 Ser58. The fusion protein was puri¢ed by IgG^Sepharose a⁄n-
ity chromatography, cleaved with Factor Xa and the trefoil protein
separated by a second passage through the IgG^Sepharose column.
TFF1 Ser58 was puri¢ed further on a 1 ml Mono Q anion exchange.
TFF1 Cys58 was ¢rst incubated with 50 mM cysteine then puri¢ed on
Mono Q, and then the dimer was separated from the residual mono-
mer by gel ¢ltration on Superdex 75 (Pharmacia). The preparation of
the 15N-labelled TFF1 proteins di¡ered only in being grown in E. coli
JM109 (monomer) and BL21 cells (dimer) in modi¢ed M9 medium
containing (15NH4)2SO4 as the sole nitrogen source.
2.2. Nuclear magnetic resonance (NMR) measurements
NMR experiments were performed on Varian Unity spectrometers
operating at 500 and 600 MHz using the same pulse sequences as
previously detailed for the monomer [20,24]. The previously reported
15N-edited heteronuclear single quantum correlation spectroscopy
(HSQC), 15N1H-nuclear Overhauser enhancement spectroscopy
(NOESY)^HSQC, 1H1H-NOESY experiments on the TFF1 Ser58
monomer carried out at 298 K and 1H1H-ROESY at 283 K in D2O
using 1 mM monomer in 4.5 mM potassium phosphate at pH* 5.9
(pH* refers to pH metre readings uncorrected for deuterium isotope
e¡ects) have been reprocessed and compared directly with the equiv-
alent spectra from TFF1 dimer.
In the case of the unlabelled dimer, 1H1H-total correlation spec-
troscopy and 1H1H-NOESY experiments were ¢rst recorded using
V1.3 mM dimer at 298 K and pH* 5.9 in 90% H2O/10% D2O with
4.5 mM potassium phosphate. The sample was then lyophilised and
redissolved in 100% D2O. A series of 1D 1H spectra and 2D 1H1H-
NOESY spectra were recorded at 298 K in the following 18 h in order
to monitor the degree of protection of any slowly exchanging amide
groups. Subsequently a 1H1H-ROESY experiment was performed on
this sample at 283 K. The sample was then lyophilised and redissolved
in 90% H2O/10% D2O; 1D proton spectra were then also recorded at
protein concentrations of V1.3 mM and 130 WM. A 2D 1H1H-NO-
ESY spectrum was recorded following the addition of 4 mM Ca2 (as
CaCl2) to the 1.3 mM dimer sample. 1D proton spectra were also
recorded using V0.5 mM dimer at pH* 5.8, 6.9 and 7.6 in the pres-
ence of 2 mM Ca2. The sample of uniformly 15N-labelled protein
was also used to measure the heteronuclear 15N{1H} steady state
nuclear Overhauser enhancement (NOE) signals and to record 2D
15N-edited HSQC and 3D 15N1H-NOESY^HSQC spectra.
2.3. Spectrum analysis
The NMR spectra were processed using nmrPipe [25], and visual-
ised and quantitated using ANSIG v3.3 [26] and XEASY [27]. The 1H
and 15N shifts were referenced as described previously [20]. Mild res-
olution enhancement was obtained by applying a Z/2 to Z/2.5 shifted
sine-squared apodisation function in all dimensions. Zero-¢lling was
employed in all indirectly detected dimensions. Linear prediction was
used to extend the data by one half in the heteronuclear dimension of
3D spectra. The ¢nal sizes of the data matrices were 8192U1024 real
points for 2D homonuclear spectra, 4096U512 for 2D heteronuclear
spectra and 1024U512U128 for 3D spectra.
2.4. Structure calculations
The structural models for both the monomer and dimer were cal-
culated using CNS 1.0 [28] with identical simulated annealing proto-
cols (2000 steps/15 fs at 50 000 K, then 5000 cooling steps/5 fs of
torsion dynamics, then 5000 steps/5 fs of cartesian dynamics cooling
from 1000 K, then 200 steps of minimisation). The structure calcula-
tions began from an extended chain using di¡erent velocities for each
repetition of the simulated annealing protocol. The protocol was re-
peated until 10 structures that satis¢ed the experimental restraints had
been found.
3. Results
3.1. Assignment and experimentally derived restraints
The earlier assignment of the spectra of the TFF1 Ser58
mutant has been described in detail [20,24]. We have now
made 35 additional NOE assignments for the monomer, re-
solving some earlier ambiguities. The sequential assignments
of the dimer were made via direct comparison of peaks in the
monomer and dimer NOESY and ROESY spectra, in con-
junction with the observed NOE connectivities in the dimer
spectra. In the 15N-edited HSQC spectra of the dimer each
pair of corresponding amino acids is represented by a single
amide peak implying that the homodimer is symmetric in its
time averaged form on the NMR timescale (ms). Conse-
quently, NOESY peaks in the dimer spectra would not neces-
sarily be assignable as speci¢cally intra- or inter-chain, how-
ever as we already have spectra of the monomeric protein we
have assumed that peaks occurring with the same chemical
shifts (1H within 0.03 ppm and 15N within 0.3 ppm) in both
monomer and dimer spectra are intra-chain. Remaining am-
biguities were largely resolved by using ambiguous NOEs in
several rounds of structure calculations, with explicit assign-
Fig. 1. A representation of the structure of TFF1 (residues 1^52
only) together with the complete native sequence (produced using
MOLSCRIPT [30]). The cysteine side chains involved in the three
characteristic disulphide linkages are numbered and shown in black.
The putative binding site is centred on residues 19, 20 and 41^43 at
the tops of the second and third loops.
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ments being made as the structural data supported them. The
sequential assignments for the TFF1 Ser58 monomer and the
TFF1 dimer have been deposited at BioMagResBank.
The restraints used here for the structure calculations of the
monomer are as described in detail previously [20], except for
the changes to some distance restraints resulting from the new
NOE assignments. The dimer restraints are identical to those
of the Ser58 monomer for residues 1^51, except for the addi-
tion of 13 distance restraints corresponding to very weak in-
tra-chain NOEs, which are discernible in the dimer spectra
because of the trefoil domain’s e¡ectively higher concentra-
tion. The angular and distance restraints for the C-terminal
tail region 52^60 are substantially di¡erent from those of the
monomer. In particular, there are 27 distance restraints for
this tail region that are persistently ambiguous as to intra- and
inter-chain assignment. In order to assess the impact of the
sparse and ambiguous nature of the restraints for this region
on the ¢nal structures, three sets of structures were calculated
in which these restraints were (i) omitted, (ii) included and (iii)
augmented by the addition of backbone torsion restraints de-
signed to restrict residues 52^60 to allowed regions of the
Ramachandran plot. As the structures generated were very
similar for all three sets of restraints, we henceforth only
consider the results of set (iii), which have been deposited,
together with the structures generated from them, as entries
r1hi7mr and 1hi7, respectively in the EBI Protein Data Bank
and are summarised in Table 1.
3.2. The dimer’s trefoil domains are intact, well separated and
do not have a ¢xed orientation
The structures derived for both monomer (Ser58 analogue)
and dimer have well-de¢ned trefoil domains (Fig. 2). The
structures for the trefoil domains (residues 7^48) are essen-
tially identical to that previously reported for TFF1 Ser58
[20]. Also the L-sheet formed by part of the N- and C-termini
(residues 3^6 and 49^51) is retained and, because of some of
the spectral ambiguities that have now been resolved, is in fact
somewhat better de¢ned in these new monomer and dimer
structures than in that previously reported [20]. Given the
sparse and ambiguous nature of inter-chain NOEs, there is
Fig. 2. A view of the ¢nal family of 10 dimer structures, created by
superimposing the residues from only one subunit at the centre of
the ¢gure. This shows that whereas an individual subunit is well de-
¢ned by the experimental data, the dimer can adopt many confor-
mations leading to a considerable variety of spacing and orientation
of the putative binding sites.
Table 1
NMR restraints and structural statistics
Monomer Dimer
Restraints used in ¢nal structure calculation:
Unambiguous NOEs: long range (Mi3jMs 4) 171 356
medium range (16 Mi3jM6 4) 111 226
sequential (Mi3jM= 1) 217 434
intra-residue 124 292
total 623 1308
Ambiguous NOEs: intra-chain 35 72
intra-/inter-chain ^ 27
Dihedral angles: B 43 48
i 49 43
M 42 38
Hydrogen bonds 8 16
Disulphide bonds 3 7
Restraint violations per structure in the ¢nal ensembles of 10 structuresa :
Number of NOE constraint violations s 0.2 Aî 0 (0) 0 (0)
Number of dihedral angle violations s 2‡ 0 (0) 0 (0)
XPLOR energies (kcal mol31)b ENOE 0.5 þ 1.0 (2.6) 1.0 þ 1.0 (2.8)
ECDIH 0.1 þ 0.2 (0.6) 0.2 þ 0.3 (1.0)
ETOTAL 19 þ 10 (43) 40 þ 9 (62)
Structural statistics for the ¢nal ensembles:
% of residues in the most favoured region of Ramachandranc 76 66d
Backbone pairwise rmsd of the trefoil domain (residues 7^47) 0.59 0.64
Heavy atom pairwise rmsd of the trefoil domain 1.42 1.38
Distance between trefoil domains (Pro20 CK to Pro20 CK)a ^ 59 þ 12(72)
aMean þ standard deviation (maximum value).
bThe force constants used to calculate ENOE were 50 kcal mol31 Aî 32 for ‘normal’ NOE constraints and 200 kcal mol31 Aî 32 for those repre-
senting hydrogen bonds. The force constant used to calculate ECDIH was 200 kcal mol31 rad32. ETOTAL was calculated using the topallhdg5.1
and parallhdg5.1 parameters with PROLSQ non-bonded interactions [31]. Some torsion angle parameters were modi¢ed to more closely re£ect
the preferences observed in high-resolution crystal structures [32].
cData from Procheck [33].
dThe lower number of residues in the most favoured region is a consequence of strain in the C-terminal tail introduced by the restraints that
are ambiguous as to inter- or intra-chain.
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no strong restraint on the relative position of the two trefoil
domains, which consequently adopt a variety of relative ori-
entations in the calculated structures (Fig. 2). In all the calcu-
lated structures, even in the set calculated with no restraints
on residues 52^60, the trefoil domains do not come into con-
tact. Implying that the overall structure is rather constrained
by the steric/packing properties of the peptide sequence near
the disulphide junction itself. The adjacent prolines kink the
chain and are relatively conformationally restricted and the
disulphide bond itself forces the C-termini to cross each other
at nearly 90‡ at Cys58. Consequently, in the majority of struc-
tures the putative binding sites are facing almost directly away
from each other with a separation of up to s 50 Aî (Pro20 CK
to Pro20 CK distance), however a few face each other and
consequently can have binding site separations as short as
36 Aî .
The results of the structure calculations are supported by
evidence from the comparison of chemical shifts and H/D
exchange behaviour of the monomer and dimer. Changes of
chemical shift of 15N and 1H backbone resonances provide an
extremely sensitive indicator of the presence of new interac-
tions in any complex on a residue-by-residue basis. Potentially
signi¢cant changes in backbone or side chain chemical shifts
are limited to residues 48^50 and the inevitable shifts around
the new disulphide linkage, residues 56^60. This again implies
no new interactions made by the trefoil domain. In the case of
the L-sheet residues 48^50, there is no evidence to indicate a
substantive change in structure, in particular the NOEs found
for these residues, including 15 between N- and C-terminal
tails, are identical in both monomer and dimer except for
the greater line width of the dimer. However this region is
known to be somewhat £exible [20] and we conclude that
the shifts are due to changes in populations of similar struc-
tures in fast exchange. The reality of the non-interaction of
the trefoil domains is also supported by the absence of di¡er-
ences in H/D exchange protection between monomer and
dimer. This indicates that no new hydrogen bonds are formed
nor are backbone accessibilities signi¢cantly altered upon for-
mation of the dimer. Additional support for the non-associa-
tion of the trefoil domains is found in our earlier observations
of the complete lack of dimerisation of the Ser58 TFF1 in
NMR [24] and analytic ultracentrifugation [16] experiments.
Data on the backbone dynamics of the dimer con¢rms the
presence of a £exible linker region in the dimer. The hetero-
nuclear NOE data for both monomer and dimer are shown in
Fig. 3, residues 55^60 have particularly low values, which are
characteristic of a high degree of £exibility. In the monomer
the free C-terminal end is very £exible indeed with negative
heteronuclear NOE values, although the C-terminal residues
are less £exible in the dimer because of the disulphide bond
formation, they still retain high mobility relative to the rest of
the structure.
3.3. The local structure is una¡ected by changes in protein
concentration, pH or Ca2+ ions
There are eight glutamate residues surrounding the Cys58^
Cys58 disulphide bond in the TFF1 dimer. Several glutamates
in close proximity can sometimes form binding sites for diva-
lent metal ions and may have also have perturbed pKa values.
We considered the possibility that the conformation of the
dimer might be modulated by changes in solution conditions.
In particular, it is tempting to speculate that these residues in
the TFF1 dimer may form a metal binding site, which may be
involved in the function or regulation of TFF1. In view of the
high calcium levels in some mucous granules [29] and the
Fig. 3. The measured 15N{1H}NOE values for the amide backbone
groups of the native sequence dimer (top) and Ser58 monomer (bot-
tom). Values below 0.5 over several successive residues indicate rap-
id local conformational change of the backbone on the ns timescale.
The N- and C-terminal tails of the dimer exhibit much of the rapid
motion seen in the monomer despite the presence of the disulphide
cross-link. This suggests that the dimer structures in Fig. 2 are rap-
idly interconverting when the dimer is free in solution. The NOE
values were measured at 14.1 T (600 MHz for 1H), zero values are
given for the prolines and for residues with peaks that cannot be
accurately quantitated due to spectral overlap, of which there are
more in the spectrum of the dimer due to its greater linewidths.
Fig. 4. A MOLSCRIPT [30] representation of the structures of
TFF2 and the TFF1 dimer, illustrating the di¡erent separation and
orientation of their trefoil domains. The secondary structure is rep-
resented only in the trefoil domain and the Cys side chains (disul-
phide bonds) are shown in black.
FEBS 24712 26-3-01
M.A. Williams et al./FEBS Letters 493 (2001) 70^74 73
possible role of trefoils in cross-linking mucins, this idea is
particularly intriguing. However, we have found no evidence
for local conformational change induced by the presence of
calcium. Similarly there is no discernible e¡ect on local struc-
ture between pH 5.6 and 7.6 (the range within which we can
prepare useful NMR samples). Neither is there any evidence
for changes in the oligomerisation of the protein with Ca2,
pH or protein concentration (between 100 WM and 1 mM).
4. Discussion
It had been previously suggested that the structures of the
TFF1 and TFF3 dimers could be very similar to the compact
structure of TFF2. Homology models of the dimers were built
on that basis in which the N- and C-terminal tail regions of
the polypeptide chain fold in such a way as to interact with
both of the trefoil domains, acting as the ‘glue’ sticking the
domains together [17]. The present work provides no evidence
for this kind of extensive interaction between the N- and C-
terminal tails and the trefoil domains of TFF1 dimer.
We have found that the two trefoil domains of the TFF1
dimer, which contain the putative receptor/ligand recognition
sites, do not adopt a ¢xed orientation with respect to one
another, but are held apart on opposite ends of a £exible
linker (Fig. 4). This observation has signi¢cant implications
for the possible mechanism of action of the TFF of proteins.
In any form of bidentate binding of the trefoil proteins, such
as might occur in their suggested role as glycoprotein cross-
linkers or for recognition of putative (dimeric?) receptors, the
relative separation and orientation of the binding sites on the
trefoil domains would obviously be important. Certainly, the
members of the trefoil family would have di¡erent reach in
any cross-linking role, for example, the closely spaced ¢xed
distance binding sites of TFF2 (44 Aî ) could be speci¢c for
achieving a particular interaction and the variable distance
(36^73 Aî ) and orientation of the TFF1 binding sites could
o¡er greater versatility at the expense of some speci¢city.
Such £exibility might be needed if TFF1 is acting as an adapt-
er molecule binding to receptor binding sites on two di¡erent
proteins and bringing them together. The TFF3 dimer, which
has a shorter C-terminal tail, perhaps provides a reach inter-
mediate between those of the other two trefoil proteins. Thus,
it seems probable that di¡erences in function/receptor specif-
icity of the members of the human TFF are not only modu-
lated by variations in amino acid composition of the putative
recognition interface [20], but also by the substantially di¡er-
ent orientation and separation of the two recognition sites in
the biologically active forms of the molecules.
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